EB-AMDK27 NEW Akkermansia muciniphila EB-AMDK27 strain AND uses thereof

摘要

The present invention is the prevention of just a novel marker cyano mu shinny pillar EB-AMDK27 strain (KCTC 13758BP), inflammation, including the strain or its culture or the dried substance diseases or metabolic diseases having an inflammatory disease or a metabolic disease prophylactic or therapeutic efficacy Or it relates to a pharmaceutical composition effective for treatment. While traditional probiotics generally have little therapeutic effect on inflammatory or metabolic diseases, the next-generation probiotic bacterium of the present invention can be used as a new prophylactic and therapeutic tool for inflammatory diseases and/or metabolic diseases. It has excellent prevention or treatment effect.